Stonepine Capital Management, LLC's most recent trades

Institution

10% Owner

COMPANY

NET TOTAL

23.75%

AMRYT PHARMA PLC - SPNR ADR

6,298,348

$44,025,000.00

11.86%

CTI BIOPHARMA CORP

3,681,195

$21,977,000.00

7.48%

ADMA BIOLOGICS INC

7,000,000

$13,860,000.00

7.12%

AMARIN CORP PLC -ADR

8,853,763

$13,192,000.00

5.23%

REZOLUTE INC

3,001,926

$9,696,000.00

5.17%

OPTINOSE INC

2,616,515

$9,576,000.00

4.91%

UROGEN PHARMA LTD

1,111,050

$9,099,000.00

4.83%

LIGAND PHARMACEUTICALS

100,244

$8,944,000.00

4.70%

AFFIMED NV

3,143,773

$8,708,000.00

4.26%

APOLLO ENDOSURGERY INC

2,161,999

$7,891,000.00

4.05%

OVID THERAPEUTICS INC

3,487,928

$7,499,000.00

3.90%

EXAGEN INC

1,260,387

$7,235,000.00

3.50%

CASTLE BIOSCIENCES INC

295,372

$6,483,000.00

3.30%

CONFORMIS INC

17,304,350

$6,122,000.00

1.28%

DIAMEDICA THERAPEUTICS INC

1,176,344

$2,376,000.00

1.02%

AERIE PHARMACEUTICALS INC

251,235

$1,884,000.00

0.99%

OPIANT PHARMACEUTICALS INC

152,278

$1,826,000.00

0.92%

ATYR PHARMA INC

601,580

$1,702,000.00

0.63%

MARINUS PHARMACEUTICALS INC

242,327

$1,173,000.00

0.55%

XOMA CORP

45,910

$1,023,000.00

0.46%

ANI PHARMACEUTICALS INC

28,800

$854,000.00

0.06%

SYNLOGIC INC

92,746

$107,000.00

0.06%

CIDARA THERAPEUTICS INC

208,443

$102,000.00